145 related articles for article (PubMed ID: 30725226)
1. Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study).
Rubio-Valera M; Peñarrubia-María MT; Iglesias-González M; Knapp M; McCrone P; Roig M; Sabes-Figuera R; Luciano JV; Mendive JM; Murrugara-Centurión AG; Alonso J; Serrano-Blanco A
Eur J Health Econ; 2019 Jul; 20(5):703-713. PubMed ID: 30725226
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
[TBL] [Abstract][Full Text] [Related]
3. A supported self-help for recurrent depression in primary care; An economic evaluation alongside a multi-center randomised controlled trial.
Biesheuvel-Leliefeld KEM; Bosmans JE; Dijkstra-Kersten SMA; Smit F; Bockting CLH; van Schaik DJF; van Marwijk HWJ; van der Horst HE
PLoS One; 2018; 13(12):e0208570. PubMed ID: 30566441
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression.
Bosmans JE; Hermens ML; de Bruijne MC; van Hout HP; Terluin B; Bouter LM; Stalman WA; van Tulder MW
J Affect Disord; 2008 Nov; 111(1):106-12. PubMed ID: 18342952
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
Nguyen KH; Gordon LG
Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
[TBL] [Abstract][Full Text] [Related]
6. One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention.
Pyne JM; Rost KM; Farahati F; Tripathi SP; Smith J; Williams DK; Fortney J; Coyne JC
Psychol Med; 2005 Jun; 35(6):839-54. PubMed ID: 15997604
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study).
Rubio-Valera M; Bosmans J; Fernández A; Peñarrubia-María M; March M; Travé P; Bellón JA; Serrano-Blanco A
PLoS One; 2013; 8(8):e70588. PubMed ID: 23950967
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a minimal intervention for stress-related sick leave in general practice: results of an economic evaluation alongside a pragmatic randomised control trial.
Uegaki K; Bakker I; de Bruijne M; van der Beek A; Terluin B; van Marwijk H; Heymans M; Stalman W; van Mechelen W
J Affect Disord; 2010 Jan; 120(1-3):177-87. PubMed ID: 19439362
[TBL] [Abstract][Full Text] [Related]
9. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
[TBL] [Abstract][Full Text] [Related]
10. Switching to sertraline or venlafaxine after failure of SSRIs treatment in major depressive disorder: an economic evaluation of the STAR*D trial.
Leelahanaj T
J Med Assoc Thai; 2012 May; 95 Suppl 5():S29-37. PubMed ID: 22934442
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.
Revicki DA; Brown RE; Keller MB; Gonzales J; Culpepper L; Hales RE
J Clin Psychiatry; 1997 Feb; 58(2):47-58. PubMed ID: 9062373
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial.
van der Aa HPA; van Rens GHMB; Bosmans JE; Comijs HC; van Nispen RMA
BMC Psychiatry; 2017 Aug; 17(1):280. PubMed ID: 28764679
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium.
Annemans L; Brignone M; Druais S; De Pauw A; Gauthier A; Demyttenaere K
Pharmacoeconomics; 2014 May; 32(5):479-93. PubMed ID: 24554474
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
[TBL] [Abstract][Full Text] [Related]
15. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
Eveleigh R; Grutters J; Muskens E; Oude Voshaar R; van Weel C; Speckens A; Lucassen P
Fam Pract; 2014 Oct; 31(5):578-84. PubMed ID: 25121977
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of depression case management in small practices.
Gensichen J; Petersen JJ; Von Korff M; Heider D; Baron S; König J; Freytag A; Krauth C; Gerlach FM; König HH
Br J Psychiatry; 2013 Jun; 202():441-6. PubMed ID: 23580379
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of watchful waiting versus antidepressants for patients diagnosed of mild to moderate depression in primary care: A 12-month pragmatic clinical trial (INFAP study).
Iglesias-González M; Aznar-Lou I; Peñarrubia-María MT; Gil-Girbau M; Fernández-Vergel R; Alonso J; Serrano-Blanco A; Rubio-Valera M
Eur Psychiatry; 2018 Sep; 53():66-73. PubMed ID: 29957370
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
19. C-QUALITY: cost and quality-of-life pharmacoeconomic analysis of antidepressants in major depressive disorder in Italy.
Mencacci C; Aguglia E; Biggio G; Cappellari L; Di Sciascio G; Fagiolini A; Maina G; Tortorella A; Katz P; Ripellino C
Adv Ther; 2013 Jul; 30(7):697-712. PubMed ID: 23929174
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
